Appetite quiets down
Most patients notice cravings, snacking and food noise drop within days of starting.
0%Avg. body-weight loss at 6 months
0%Of patients see appetite drop in week 1
0+Women treated through Gala
How it works
Same molecule, no needle
Oral semaglutide uses an absorption enhancer that protects the molecule through the stomach so it can reach the bloodstream from a single daily pill. Trial data shows weight-loss efficacy approaching the injectable form.
The data
Sustained loss, month after month.
Six-month trajectories from clinical data of the underlying molecules. GLP-1 produces continued, compounding loss; lifestyle changes alone tend to plateau and rebound.
Outcomes
Why GLP-1 outperforms willpower
GLP-1 + provider care−20%
GLP-1 alone−15%
Diet + exercise−5%
No treatment−1%
What to expect
Your first six months on Wegovy® pill.
Every body is different. These are the patterns we see most often across thousands of women on this protocol.
First visible loss
Body-weight reduction starts showing up on the scale and in how clothes fit.
Loss compounds
Steady weekly loss with provider-guided dose titration. Mood and energy stabilize.
Sustained results
Average 15–20% body weight reduction in clinical data, with maintenance protocols built in.
Is it right for you
Wegovy® pill works best for…
- Strongly prefer oral medication over injections
- Have needle phobia or injection-site sensitivity
- Want the latest oral GLP-1 weight-loss option
How to start
From assessment to treatment in a week.
Take the assessment
Quick health questionnaire — about 5 minutes. We use it to match you to the right medication and dose.
Provider review
A US-licensed clinician reviews your full profile and either prescribes or comes back with a question.
Medication ships
Your medication arrives free of charge with everything you need to start. Provider support is included.
Frequently asked questions
When will it be available?
Pending FDA approval and supply. Join the waitlist and we'll email you the moment it's available through Gala.
How does it compare to injectable semaglutide?
Trial data suggests comparable weight-loss outcomes. Oral has a different side-effect profile and requires consistent timing relative to meals.